1. Comparative efficacy of an optimal exam between ultrasound versus abbreviated <scp>MRI</scp> for <scp>HCC</scp> screening in <scp>NAFLD</scp> cirrhosis: A prospective study
- Author
-
Daniel Q. Huang, Kathryn J. Fowler, Joy Liau, Guilherme M. Cunha, Ashley L. Louie, Julie Y. An, Ricki Bettencourt, Jinho Jung, Zachary Gitto, Christie Hernandez, Scarlett J. Lopez, Hersh Gupta, Claude B. Sirlin, Robert M. Marks, and Rohit Loomba
- Subjects
Liver Cirrhosis ,Male ,Carcinoma, Hepatocellular ,Hepatology ,Liver Neoplasms ,Gastroenterology ,Contrast Media ,Middle Aged ,Magnetic Resonance Imaging ,Article ,Non-alcoholic Fatty Liver Disease ,Humans ,Female ,Pharmacology (medical) ,Prospective Studies ,Retrospective Studies - Abstract
BACKGROUND: Retrospective studies report that visualisation of the liver may be severely limited using ultrasound (US), potentially contributing to diminished sensitivity for detection of hepatocellular carcinoma (HCC) among patients with nonalcoholic fatty liver disease (NAFLD) and cirrhosis, but there are limited prospective data. AIMS: To compare liver visualisation scores prospectively for US and abbreviated hepatobiliary phase (HBP) magnetic resonance imaging (AMRI) in a cohort of participants with NAFLD cirrhosis and a clinical indication for HCC surveillance. METHODS: This prospective multicenter study included 54 consecutive participants (67% women) with NAFLD cirrhosis who underwent contemporaneous US as well as HBP-AMRI with gadoxetic acid. Primary outcome was the proportion of imaging examinations with severe limitations in liver visualisation (visualisation score C) compared head-to-head between US and AMRI. RESULTS: The mean (± standard deviation) age was 63.3 years (±8.4) and body mass index was 32.0 kg/m(2) (±6.0). Nineteen participants (35%) had severe visualisation limitations on US, compared with 10 (19%) with AMRI, p < 0.0001. Nine (17%) participants had
- Published
- 2022
- Full Text
- View/download PDF